Vertex Pharmaceuticals VRTX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's current ratio?
- Vertex Pharmaceuticals (VRTX) reported current ratio of 3× in Q1 2026.
- How has Vertex Pharmaceuticals's current ratio changed year-over-year?
- Vertex Pharmaceuticals's current ratio increased by 14.3% year-over-year, from 2.6× to 3×.
- What is the long-term trend for Vertex Pharmaceuticals's current ratio?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's current ratio has grown at a -12.9% compound annual growth rate (CAGR), from 18.1× to 10.4×.
- What does current ratio mean?
- Whether the company has enough short-term assets to cover its short-term bills.
- How do you interpret current ratio?
- Above 1.0 means short-term assets cover short-term liabilities. Very high values can signal idle cash or bloated inventory/receivables rather than strength — there's a healthy middle, not 'more is better'.
- How does current ratio compare across companies?
- Comparable within an industry. Working-capital-light businesses can operate safely below 1.0 by collecting before they pay.